LINC01133 hampers the development of gastric cancer through increasing somatostatin via binding to microRNA-576-5p

Epigenomics. 2021 Aug;13(15):1205-1219. doi: 10.2217/epi-2020-0377. Epub 2021 Jul 28.

Abstract

Aim: Our study aimed at investigating how LINC01133 functions in gastric cancer (GC) progression. Materials & methods: Gain-of-function and loss-of-function approaches were applied to analyze the effects of LINC01133, microRNA-576-5p (miR-576-5p) and somatostatin (SST) on the biological behaviors of GC cells and in tumor-bearing nude mice. Results: GC tissues and cells showed low expression of LINC01133, and LINC01133 overexpression decreased malignant phenotypes of GC cells. Moreover, LINC01133 upregulated SST through binding to miR-576-5p. Overexpressing miR-576-5p or suppressing SST reversed the functions of LINC01133 in biological potentials of GC cells and tumor growth. Conclusion: LINC01133 overexpression may inhibit GC development by downregulation of miR-576-5p and upregulation of SST, which suggests new therapeutic targets for GC.

Keywords: LINC01133; SST; apoptosis; gastric cancer; invasion; microRNA-576-5p; migration; progression; proliferation; therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Databases, Genetic
  • Disease Models, Animal
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mice
  • MicroRNAs / genetics*
  • Models, Biological
  • RNA Interference*
  • RNA, Long Noncoding / genetics*
  • Somatostatin / biosynthesis*
  • Somatostatin / genetics
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / metabolism*
  • Stomach Neoplasms / pathology
  • Transcriptome

Substances

  • MIRN576 microRNA, human
  • MicroRNAs
  • RNA, Long Noncoding
  • Somatostatin